申请人:Takeda Chemical Industries, Ltd.
公开号:EP1466904A1
公开(公告)日:2004-10-13
The present invention provides a compound having melanocortin receptor agonist activity or antagonist activity, which is a novel biaryl compound represented by the formula (I) :
wherein ring A and ring B are optionally further substituted 6-membered aromatic rings; X is -CONR4-, -SO2NR4-, -CH2NR4- (R4is a hydrogen atom, an optionally substituted hydrocarbon group, etc.), etc.; Y is a spacer having 1 to 12 atoms, etc.; Z is -CONR6-, -CO- (R6 is a hydrogen atom, an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group), etc.; R1 is an optionally substituted amino group, etc.; R2 is an optionally substituted hydrocarbon group, etc.; R3 is an optionally substituted hydrocarbon group, etc.; and R5 is an optionally substituted hydrocarbon group, etc.; or a salt thereof.
本发明提供了一种具有黑色素皮质素受体激动剂活性或拮抗剂活性的化合物,它是由式(I)表示的新型双芳基化合物:
其中环 A 和环 B 是任选进一步取代的 6 元芳香环;X 是-CONR4-、-SO2NR4-、-CH2NR4-(R4 是氢原子、任选取代的烃基等)等;Y 是具有 1 至 12 个原子的间隔物等。Z 是-CONR6-、-CO-(R6 是氢原子、任选取代的烃基或任选取代的杂环基)等;R1 是任选取代的氨基等;R2 是任选取代的烃基等;R3 是任选取代的烃基等;R5 是任选取代的烃基等;或其盐。